These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1797433)

  • 21. Synthesis and biological activity of novel thiazolidinediones.
    Prabhakar C; Madhusudhan G; Sahadev K; Reddy CM; Sarma MR; Reddy GO; Chakrabarti R; Rao CS; Kumar TD; Rajagopalan R
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2725-30. PubMed ID: 9873611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troglitazone, an euglycemic antidiabetic drug.
    Vyas K; Sivalakshmidevi A; Prabhakar C; Reddy GO
    Acta Crystallogr C; 1999 Mar; 55 ( Pt 3)():411-3. PubMed ID: 10220869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic toxicity in monkeys with the thiazolidinedione antidiabetic agent troglitazone.
    Rothwell C; McGuire EJ; Altrogge DM; Masuda H; de la Iglesia FA
    J Toxicol Sci; 2002 Feb; 27(1):35-47. PubMed ID: 11915367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coadministration of acetaminophen and troglitazone: pharmacokinetics and safety.
    Young MA; Lettis S; Eastmond R
    J Clin Pharmacol; 1998 Sep; 38(9):819-24. PubMed ID: 9753210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Troglitazone, a new antidiabetic agent, decreases cyclosporine level.
    Park MH; Pelegrin D; Haug MT; Young JB
    J Heart Lung Transplant; 1998 Nov; 17(11):1139-40. PubMed ID: 9855455
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.
    Fujiwara T; Wada M; Fukuda K; Fukami M; Yoshioka S; Yoshioka T; Horikoshi H
    Metabolism; 1991 Nov; 40(11):1213-8. PubMed ID: 1943750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged effect of troglitazone (CS-045) on xenograft survival of hybrid artificial pancreas.
    Kawakami Y; Inoue K; Tun T; Hayashi H; Setoyama H; Gu YJ; Cui WX; Imamura M; Iwata H; Ikada Y
    Cell Transplant; 1997; 6(5):547-50. PubMed ID: 9331511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low density lipoprotein in vitro.
    Nagasaka Y; Kaku K; Nakamura K; Kaneko T
    Biochem Pharmacol; 1995 Sep; 50(7):1109-11. PubMed ID: 7575669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal absorption and excretion of troglitazone sulphate, a major biliary metabolite of troglitazone.
    Kawai K; Hirota T; Muramatsu S; Tsuruta F; Ikeda T; Kobashi K; Nakamura KI
    Xenobiotica; 2000 Jul; 30(7):707-15. PubMed ID: 10963061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone).
    Sohda T; Ikeda H; Meguro K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2168-72. PubMed ID: 8582019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives.
    Sohda T; Mizuno K; Imamiya E; Sugiyama Y; Fujita T; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3580-600. PubMed ID: 7160012
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones.
    Oguchi M; Wada K; Honma H; Tanaka A; Kaneko T; Sakakibara S; Ohsumi J; Serizawa N; Fujiwara T; Horikoshi H; Fujita T
    J Med Chem; 2000 Aug; 43(16):3052-66. PubMed ID: 10956213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of an antidiabetic agent, (+/-)-5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazollidine, troglitazone dihydrate.
    Kobayashi K; Fukuhara H; Hata T
    Anal Sci; 2001 Mar; 17(3):467-8. PubMed ID: 11990631
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
    Madhavan GR; Chakrabarti R; Kumar SK; Misra P; Mamidi RN; Balraju V; Kasiram K; Babu RK; Suresh J; Lohray BB; Lohrayb VB; Iqbal J; Rajagopalan R
    Eur J Med Chem; 2001; 36(7-8):627-37. PubMed ID: 11600232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds.
    Sohda T; Mizuno K; Tawada H; Sugiyama Y; Fujita T; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3563-73. PubMed ID: 7160011
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats.
    Kostrubsky VE; Vore M; Kindt E; Burliegh J; Rogers K; Peter G; Altrogge D; Sinz MW
    Drug Metab Dispos; 2001 Dec; 29(12):1561-6. PubMed ID: 11717175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troglitazone in type II diabetes mellitus.
    Sparano N; Seaton TL
    Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro.
    Gralinski MR; Rowse PE; Breider MA
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):909-13. PubMed ID: 9641476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
    Wang M; Wise SC; Leff T; Su TZ
    Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats.
    Fujiwara T; Ohsawa T; Takahashi S; Ikeda K; Okuno A; Ushiyama S; Matsuda K; Horikoshi H
    Life Sci; 1998; 63(22):2039-47. PubMed ID: 9839548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.